Navigation Links
Growth of cardiac services linked to competition, not improved patient care, study finds

New interventional cardiac catheterization services offered by U.S. hospitals generally duplicate existing programs and do not help patients gain access to timely emergency cardiac care, according to a new study.

Examining new cardiac catheterization programs nationally from 2004 to 2008, researchers found the programs were most likely to be introduced in areas that had existing services, near populations that had higher rates of private health insurance and in states where there is little oversight of hospitals.

The findings are published online by the journal Circulation: Cardiovascular Quality and Outcomes.

"New interventional cardiac catheterization programs have not been located in areas where they can help patients gain timely access to needed heart services. Instead, the focus has been on competing with other hospitals," said Thomas W. Concannon, the study's lead author and a policy researcher at RAND, a nonprofit research organization. "The widespread expansion of this service has added significantly to health care costs and there is now strong evidence that it has not improved patient care."

Cardiac catheterization laboratories can provide life-saving treatment by allowing doctors to open clogged heart arteries that may trigger a heart attack. Although about 80 percent of the nation's population lives within a 60-minute drive of a catheterization laboratory, fewer than half of the patients who suffer heart attacks get access to the treatment in an emergency.

The new study is the first to examine the growth of cardiac catheterization laboratories over time, allowing investigators to assess whether new programs duplicate existing services and identify the factors associated with the decision to introduce a new program.

Researchers found that while the number of cardiac catheterization programs at the nation's 4,544 acute care hospitals increased by 16.5 percent from 2004 to 2008, the percentage of the U.S. population with timely access to heart catheterization services increased by just 1.8 percent. Researchers estimate the 251 new cardiac catheterization programs created during the study period cost $2 billion to $4 billion.

In general, researchers found the new cardiac catheterization programs targeted neighborhoods already served by other programs, where competition for patients was already high and where timely access for patients did not improve.

There were some exceptions to the findings. Access to cardiac catheterization programs in Mississippi grew sharply during the study period and in Missouri the growth in programs led to a meaningful drop in projected transport times for patients, according to the study.

Although the pace of new cardiac catheterization programs slowed during the study period, expansions continue at a fast pace. Researchers say policymakers should consider three approaches that could be used to improve access to cardiac catheterization services while restraining duplication of services.

The options include voluntary systems where hospitals and emergency medical providers work to provide services to more people while avoiding duplication. The largest example of such a system is the North Carolina Regional Approach to Cardiovascular Emergencies, or RACE protocol.

Another approach is to use market-based solutions to discourage duplication of cardiac catheterization programs. This could include reducing payment for the service, which could discourage new investments.

The final approach is state review and approval of plans to establish cardiac catheterization labs or similar technology. Twenty-seven states already use the approach, and the study found that hospitals in states with a robust oversight program were 40 percent less likely to introduce a new catheterization program in any given year.


Contact: Warren Robak
RAND Corporation

Related medicine news :

1. Health info exchange: Short-term growth, but long-term concerns
2. Growth in cerebral aneurysms increases risk of rupture
3. Study links cardiac hormone-related inflammatory pathway with tumor growth
4. Ethanol Leads Renewable Chemicals Market; Polymers Sector 14.3% CAGR Growth Forecasted by 2018 Says New Research Report at
5. Study shows how the Nanog protein promotes growth of head and neck cancer
6. Gene signature test diagnoses benign thyroid growths
7. Global Medical Simulation Products & Services Market Growth Forecasts to 2017 in a New Research Report at
8. Impact with Martin Sheen Reporting on the Growth in the Homeopathy Industry
9. Doctor Evidence, LLC Closes 2012 With Strong Sales Growth
10. Metabolic molecule drives growth of aggressive brain cancer
11. iVantage Health Analytics Raises $10M in Equity to Further Accelerate Growth
Post Your Comments:
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: